- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01267539
Suan Tsao Jen Tang for Treating Menopause With Sleep Problem: a Clinical Observation
December 27, 2010 updated by: Taipei City Hospital
A prospective follow-up study was carried out in the Yang Ming branch of the Taipei City Hospital.Climacteric women with sleep difficulty received SZRT at a rate of 4.0 g, thrice daily for four weeks.
Study Overview
Status
Completed
Conditions
Detailed Description
A prospective follow-up study was carried out in the Yang Ming branch of the Taipei City Hospital between April 2008 and April 2010.
Sixty-seven climacteric women with sleep difficulty received SZRT at a rate of 4.0 g, thrice daily for four weeks.
Baseline scores were measured on the Pittsburg Sleep Quality Index (PSQI), followed by further measures at the end of weeks one and four.
The World Health Organization Quality of Life (WHOQOL) assessment and the Menopause Rating Scale (MRS) were undertaken as secondary outcomes.
Regression models were constructed to explore the score differences between the baseline and at weeks one and four by various determinants including age, body mass index (BMI), and severity of baseline menopausal symptoms.
Among 99 surveyed patients, 67 and 61 were screened for intention to treat (ITT) and per-protocol population set analysis, respectively.
Statistically significant reductions in the PSQI index scores evidenced on the fourth week.
Study Type
Observational
Enrollment (Actual)
67
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 111
- Taipei City Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
The subjects enrolled in the study were climacteric women, ranging from 40-65 years of age, with a Pittsburg Sleep Quality Index (PSQI) of greater than six.
These women spent 45 minutes or more falling asleep, slept less than six hours, and had struggled with this issue continuously for at least one month.
Description
Inclusion Criteria:
- Climacteric women, ranging from 40-65 years of age
- Pittsburg Sleep Quality Index (PSQI) of greater than six
- Falling asleep more than 45 minutes or slept less than six hours
Exclusion Criteria:
- Within three months of the study there had been a major incident
- Working the nightshift
- Lack of time or timing conflicts
- Pychosis, severe depression, obstructive sleep apnea-hypopnea, cardiac arrhythmia, acute myocardial infarction, high blood pressure, diabetes, or cancer
- Currently taking pharmaceuticals that affect melatonin, acetylcholine, glutamate, serotonin, norepinephrine, GABA, histamine, adenosine, or prostaglandins
- Inability to read and fill out the forms for the study
- Any evidence of renal or liver dysfunction as defined by a level of at least 1.5 times of the upper reference limit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Jung-Nien Lai, PHD, Taipei City Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
April 1, 2010
Study Registration Dates
First Submitted
December 20, 2010
First Submitted That Met QC Criteria
December 27, 2010
First Posted (Estimate)
December 28, 2010
Study Record Updates
Last Update Posted (Estimate)
December 28, 2010
Last Update Submitted That Met QC Criteria
December 27, 2010
Last Verified
January 1, 2008
More Information
Terms related to this study
Other Study ID Numbers
- TCHIRB-970110-E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopausal and Female Climacteric States
-
GlaxoSmithKlineCompletedMenopausal and Female Climacteric StatesUnited States, Australia, Argentina, Germany, United Kingdom, Spain, Italy, New Zealand, Sweden
-
University of ValenciaCompleted
-
Legacy Health SystemUnknownMenopause | Climacteric; Menorrhagia, MenopausalUnited States
-
Ache Laboratorios Farmaceuticos S.A.Withdrawn
-
Inna I. KovalenkoCompletedClimacteric SyndromeRussian Federation
-
Science Valley Research InstituteBiós FarmacêuticaRecruitingMenopause | Hypoestrogenism | Climacteric SyndromeBrazil
-
I.M. Sechenov First Moscow State Medical UniversityCompletedPerimenopause, Climacteric SyndromeRussian Federation
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause | Climacteric SyndromeRussian Federation
-
National Taiwan University HospitalDepartment of HealthCompletedClimacteric Symptoms | Hot Flushes and/or Sweats